Menu
GeneBe

NUP98

nucleoporin 98 and 96 precursor, the group of Nucleoporins

Basic information

Region (hg38): 11:3671082-3797792

Links

ENSG00000110713NCBI:4928OMIM:601021HGNC:8068Uniprot:P52948AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NUP98 gene.

  • Inborn genetic diseases (54 variants)
  • not provided (14 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUP98 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
clinvar
6
missense
51
clinvar
4
clinvar
5
clinvar
60
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
2
non coding
0
Total 0 0 51 7 8

Variants in NUP98

This is a list of pathogenic ClinVar variants found in the NUP98 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-3676173-C-T not specified Uncertain significance (Jul 26, 2022)2303124
11-3676184-C-T not specified Uncertain significance (Jan 24, 2024)3203311
11-3676209-G-A not specified Uncertain significance (May 11, 2022)2288826
11-3676283-C-T not specified Uncertain significance (Nov 10, 2022)3203310
11-3676333-A-G Benign (Dec 28, 2017)726791
11-3676347-G-A not specified Uncertain significance (Jan 10, 2023)2460497
11-3676355-T-C Hirschsprung disease, susceptibility to, 1 Likely pathogenic (Sep 27, 2016)375277
11-3676364-C-T Benign (Jan 05, 2018)732243
11-3676513-C-G not specified Uncertain significance (Dec 08, 2023)3203309
11-3676560-G-A not specified Uncertain significance (Apr 28, 2022)2369043
11-3676587-G-T not specified Uncertain significance (Mar 07, 2024)3203307
11-3679564-T-C not specified Likely benign (Aug 02, 2022)2371894
11-3679582-A-G not specified Uncertain significance (Jun 12, 2023)2513735
11-3679586-T-C not specified Uncertain significance (Sep 06, 2022)2363428
11-3679613-A-G not specified Benign (-)992658
11-3679685-C-T not specified Uncertain significance (Dec 12, 2023)3203306
11-3683214-C-T Benign (Dec 31, 2019)718546
11-3685998-C-T not specified Uncertain significance (Jun 12, 2023)2559631
11-3686180-T-C not specified Uncertain significance (May 26, 2022)3203304
11-3691425-C-T not specified Likely benign (Mar 01, 2024)3203303
11-3693260-G-A Likely benign (Jun 08, 2018)785886
11-3693307-A-G Likely benign (Dec 31, 2019)798039
11-3693342-C-T not specified Uncertain significance (Nov 22, 2023)3203302
11-3695477-C-T not specified Uncertain significance (Feb 28, 2024)3203301
11-3695492-T-G not specified Uncertain significance (Nov 06, 2023)3203300

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NUP98protein_codingprotein_codingENST00000324932 32126710
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.006.31e-11125737091257460.0000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.418459680.8730.000050911690
Missense in Polyphen347464.650.74685774
Synonymous-0.2163513461.010.00001683639
Loss of Function8.11586.40.05790.000004631018

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00005310.0000527
Middle Eastern0.000.00
South Asian0.00003560.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. NUP98 and NUP96 are involved in the bidirectional transport across the NPC. May anchor NUP153 and TPR to the NPC. In cooperation with DHX9, plays a role in transcription and alternative splicing activation of a subset of genes (PubMed:28221134). Involved in the localization of DHX9 in discrete intranuclear foci (GLFG-body) (PubMed:28221134). {ECO:0000269|PubMed:15229283}.;
Disease
DISEASE: Note=A chromosomal aberration involving NUP98 is found in a form of acute myeloid leukemia. Translocation t(7;11)(p15;p15) with HOXA9. Translocation t(11;17)(p15;p13) with PHF23. {ECO:0000269|PubMed:16028218}.; DISEASE: Note=A chromosomal aberration involving NUP98 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NSD1. Translocation t(8;11)(p11.2;p15) with WHSC1L1. {ECO:0000269|PubMed:16028218}.; DISEASE: Note=A chromosomal aberration involving NUP98 is found in a form of therapy-related myelodysplastic syndrome. Translocation t(11;20)(p15;q11) with TOP1. {ECO:0000269|PubMed:16028218}.; DISEASE: Note=A chromosomal aberration involving NUP98 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(3;11)(q12.2;p15.4) with LNP1. {ECO:0000269|PubMed:16028218}.; DISEASE: Note=A chromosomal aberration involving NUP98 is associated with pediatric acute myeloid leukemia (AML) with intermediate characteristics between M2-M3 French-American-British (FAB) subtypes. Translocation t(9;11)(p22;p15) with PSIP1/LEDGF. The chimeric transcript is an in-frame fusion of NUP98 exon 8 to PSIP1/LEDGF exon 4. {ECO:0000269|PubMed:16028218}.; DISEASE: Note=A chromosomal aberration involving NUP98 has been identified in acute leukemias. Translocation t(6;11)(q24.1;p15.5) with CCDC28A. The chimeric transcript is an in-frame fusion of NUP98 exon 13 to CCDC28A exon 2. Ectopic expression of NUP98- CCDC28A in mouse promotes the proliferative capacity and self- renewal potential of hematopoietic progenitors and rapidly induced fatal myeloproliferative neoplasms and defects in the differentiation of the erythro-megakaryocytic lineage. {ECO:0000269|PubMed:16028218}.;
Pathway
Influenza A - Homo sapiens (human);RNA transport - Homo sapiens (human);tRNA processing;Disease;Signal Transduction;Gene expression (Transcription);Regulation of HSF1-mediated heat shock response;Metabolism of carbohydrates;Rev-mediated nuclear export of HIV RNA;Late Phase of HIV Life Cycle;HIV Life Cycle;Interactions of Rev with host cellular proteins;Host Interactions of HIV factors;HIV Infection;snRNP Assembly;Vpr-mediated nuclear import of PICs;SUMOylation of DNA damage response and repair proteins;Transport of Ribonucleoproteins into the Host Nucleus;Viral Messenger RNA Synthesis;Export of Viral Ribonucleoproteins from Nucleus;SUMOylation of chromatin organization proteins;Influenza Viral RNA Transcription and Replication;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMOylation of DNA replication proteins;SUMO E3 ligases SUMOylate target proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Metabolism of proteins;Influenza Life Cycle;Influenza Infection;Metabolism of RNA;Glycolysis and Gluconeogenesis;Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal;Amplification of signal from the kinetochores;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Infectious disease;Leukotriene metabolism;Squalene and cholesterol biosynthesis;Purine metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;RHO GTPases Activate Formins;Pyrimidine metabolism;SUMOylation;Glycosphingolipid metabolism;Cellular responses to external stimuli;Regulation of Glucokinase by Glucokinase Regulatory Protein;Glycolysis;RHO GTPase Effectors;Phosphatidylinositol phosphate metabolism;Signaling by Rho GTPases;Lysine metabolism;Methionine and cysteine metabolism;Selenoamino acid metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Aminosugars metabolism;Pentose phosphate pathway;Nuclear Pore Complex (NPC) Disassembly;De novo fatty acid biosynthesis;Glycerophospholipid metabolism;Prostaglandin formation from dihomo gama-linoleic acid;Putative anti-Inflammatory metabolites formation from EPA;Vitamin D3 (cholecalciferol) metabolism;Vitamin E metabolism;tRNA processing in the nucleus;Transport of Mature mRNA derived from an Intron-Containing Transcript;Metabolism of non-coding RNA;Cellular response to heat stress;Nuclear Envelope Breakdown;Mitotic Prophase;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Nuclear import of Rev protein;Glucose metabolism;Transcriptional regulation by small RNAs;Cell Cycle;Resolution of Sister Chromatid Cohesion;Interactions of Vpr with host cellular proteins;Glycine, serine, alanine and threonine metabolism;Cell Cycle, Mitotic;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Arachidonic acid metabolism;Gene Silencing by RNA (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.00393
rvis_EVS
-1.29
rvis_percentile_EVS
5.01

Haploinsufficiency Scores

pHI
0.934
hipred
Y
hipred_score
0.697
ghis
0.578

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.912

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nup98
Phenotype
growth/size/body region phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
nup98
Affected structure
cerebellar central artery
Phenotype tag
abnormal
Phenotype quality
hemorrhagic

Gene ontology

Biological process
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery;DNA replication;RNA export from nucleus;mRNA export from nucleus;proteolysis;protein import into nucleus;nucleocytoplasmic transport;nuclear pore organization;viral process;telomere tethering at nuclear periphery;positive regulation of mRNA splicing, via spliceosome;nuclear pore complex assembly;positive regulation of nucleic acid-templated transcription
Cellular component
kinetochore;nuclear envelope;nuclear pore;nucleoplasm;cytosol;nuclear body;nuclear pore outer ring;nuclear membrane;nuclear periphery;nuclear inclusion body;intracellular membrane-bounded organelle;nuclear pore cytoplasmic filaments;nuclear pore nuclear basket;ribonucleoprotein complex
Molecular function
transcription coactivator activity;RNA binding;mRNA binding;transporter activity;protein binding;nuclear localization sequence binding;serine-type peptidase activity;structural constituent of nuclear pore;promoter-specific chromatin binding